Luveltamab Tazevibulin
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Luveltamab Tazevibulin, covering 2025-08-22 to 2025-09-23. Get the full timeline:
Most recent: Clinical Trial Update: REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1 [Phase 2, Phase 3]